Alain Hovnanian Selected Research

Chemokine CCL17

2/2013

Netherton syndrome: skin inflammation and allergy by loss of protease inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alain Hovnanian Research Topics

Disease

32	Netherton Syndrome 02/2024 - 02/2002
18	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 12/2023 - 09/2002
12	Inflammation (Inflammations) 02/2024 - 08/2007
10	Skin Diseases (Skin Disease) 02/2024 - 09/2007
8	Atopic Dermatitis (Atopic Eczema) 06/2024 - 05/2009
8	Darier Disease (Darier's Disease) 07/2014 - 09/2003
7	Genetic Skin Diseases 12/2016 - 10/2004
5	Hypersensitivity (Allergy) 10/2023 - 02/2008
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 04/2010
4	Blister (Bulla) 01/2022 - 07/2003
4	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 01/2022 - 04/2006
4	Hidradenitis Suppurativa 10/2020 - 11/2015
4	Benign Familial Pemphigus (Hailey Hailey Disease) 02/2006 - 02/2002
3	Ichthyosis (Xeroderma) 10/2023 - 10/2010
3	Neoplasms (Cancer) 10/2023 - 01/2018
2	Rosacea (Acne Rosacea) 01/2023 - 08/2007
2	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 03/2021 - 06/2016
2	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 01/2020 - 01/2019
2	Erythema 01/2020 - 03/2010
2	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 06/2017 - 10/2010
2	Exfoliative Dermatitis (Erythroderma) 03/2014 - 02/2002
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 07/2011 - 02/2008
2	Infections 09/2007 - 10/2006
2	Lamellar Ichthyosis (Harlequin Ichthyosis) 03/2007 - 07/2005
1	Arthralgia (Joint Pain) 10/2023
1	Diarrhea 10/2023
1	Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome) 01/2023
1	Dysbiosis 01/2023
1	Bullous Pemphigoid (Pemphigoid) 03/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 07/2020
1	Job Syndrome (Hyper-IgE Syndrome) 01/2020
1	Pain (Aches) 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Epidermolysis Bullosa 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Virus Diseases (Viral Diseases) 10/2017
1	Wounds and Injuries (Trauma) 01/2016
1	Pyoderma Gangrenosum 11/2015
1	Acne Vulgaris 11/2015
1	Erythrokeratodermia Variabilis 06/2015

Drug/Important Bio-Agent (IBA)

17	Peptide Hydrolases (Proteases)FDA Link 02/2024 - 01/2005
16	Collagen Type VIIIBA 01/2023 - 03/2006
14	Kallikreins (Kallikrein)IBA 01/2023 - 05/2009
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
11	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2021 - 10/2003
9	Serine Peptidase Inhibitor Kazal-Type 5IBA 02/2024 - 02/2002
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 07/2006
6	Adenosine Triphosphatases (ATPase)IBA 02/2006 - 02/2002
5	Serine Proteases (Serine Protease)IBA 01/2022 - 08/2007
4	Keratins (Keratin)IBA 06/2017 - 12/2003
3	CathelicidinsIBA 01/2023 - 10/2006
3	Immunoglobulin E (IgE)IBA 01/2022 - 02/2002
3	LipidsIBA 05/2014 - 07/2005
3	Thymic Stromal LymphopoietinIBA 03/2014 - 05/2009
3	CalciumIBA 05/2011 - 12/2003
3	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 10/2006 - 09/2003
3	Protein Isoforms (Isoforms)IBA 02/2006 - 09/2003
2	baricitinibIBA 06/2024 - 10/2023
2	CytokinesIBA 02/2024 - 02/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 01/2020
2	AutoantibodiesIBA 03/2021 - 06/2016
2	Filaggrin ProteinsIBA 03/2014 - 03/2010
2	TrypsinIBA 01/2013 - 07/2006
2	Keratin-14 (Keratin 14)IBA 10/2011 - 04/2006
2	HLA-B Antigens (HLA-B)IBA 07/2011 - 02/2008
2	pancreatic elastase IIIBA 08/2010 - 03/2010
2	Nevirapine (Viramune)FDA Link 02/2008 - 02/2008
1	interleukin 20 (IL-20)IBA 02/2024
1	Interleukin-17 (Interleukin 17)IBA 02/2024
1	RibonucleoproteinsIBA 12/2023
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	InterferonsIBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	ixekizumabIBA 05/2021
1	IndolesIBA 10/2020
1	Tryptophan (L-Tryptophan)FDA Link 10/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2020
1	dupilumabIBA 01/2020
1	staphylococcal delta toxinIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	secukinumabIBA 01/2020
1	ON 01910IBA 01/2019
1	Keratin-5 (Keratin 5)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	APOBEC DeaminasesIBA 01/2018
1	diacereinIBA 01/2018
1	Antiviral Agents (Antivirals)IBA 10/2017
1	VaccinesIBA 10/2017
1	Antisense OligoribonucleotidesIBA 12/2016
1	Ertapenem (Invanz)FDA Link 02/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2015
1	ConnexinsIBA 06/2015
1	matriptaseIBA 01/2015
1	AllergensIBA 10/2014
1	miglustat (Zavesca)FDA Link 07/2014
1	EnzymesIBA 06/2014

Therapy/Procedure

10	Therapeutics 01/2022 - 09/2002
1	Subcutaneous Injections 12/2016